Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-16

Clinical Trial Update: Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma [NA]

View source ↗

Summary

A clinical trial (NCT04196933) evaluating vestibular compensation after intervention for vestibular schwannoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Migraine, Vestibular Migraine | NA | Status: WITHDRAWN